首页> 外文期刊>Internet Journal of Hematology >Pattern of Haematological Malignancies in Ilorin, Nigeria: A Ten Year Review
【24h】

Pattern of Haematological Malignancies in Ilorin, Nigeria: A Ten Year Review

机译:尼日利亚伊洛林的血液系统恶性肿瘤类型:十年回顾

获取原文
           

摘要

A 10 year retrospective survey of haematological malignancies in Ilorin, Nigeria, was carried out based on data from the Records Department and the Cancer Registry of the Morbid Anatomy Department of the University of Ilorin Teaching Hospital.The aim was to determine the current pattern of haematological malignancies in the study area and compare with previous reports from other parts of Nigeria and worldwide.A total of 370 cases of haematological malignancies which were diagnosed within the study period (January 1996 to December 2005) by means of available haematological laboratory methods and histological examinations were analyzed. The distribution of the various haematological malignancies recorded were: ALL 18(4.9%), AML 18(4.9%), CLL 20(5.4%), CML 42(11.4%), Hairy cell leukaemia 2(0.5%), NHL 104(28.1%), Hodgkin’s disease 42(11.4%), Burkitt’s lymphoma 102(27.5%), Multiple myeloma 20 (5.4%) and Plasma cell leukaemia 2(0.5%)The lymphomas were found to constitute the highest prevalence (67.0%), with non-Hodgkin’s lymphoma being the commonest, accounting for about 42% of the lymphoma cases. Hairy cell leukaemia and plasma cell leukaemia were the least seen, each constituting 0.5% of the cases.The distribution of the various haematological malignancies in this study is similar to the pattern reported in previous studies, although, there appears to be generally a lower prevalence of haematological malignancies recorded when compared to the earlier findings.Difficulties in management and poor outcome observed for the various haematological malignancies are attributable to late presentation, high patients default rate, poverty and shortage of chemotherapeutic agents. Introduction Haematological malignancies are primary cancers of the blood and blood forming organs i.e. the bone marrow and lymphoid tissues. They are usually clonal in origin and are quite often associated with chromosomal abnormalities [1]. These malignancies are induced by genetic damage or mutation in somatic cells, which can result from environmental agents such as chemicals, ionizing radiation and viral agents. The pattern of clinical presentation of these malignancies is variable and depends largely on the nature of the disease and its extent. They have a worldwide distribution and can occur at all ages and in both sexes. Although, there are differences between the various types as regards the age and sex incidence, a changing pattern in the clinical presentation and distribution has been reported in various communities over the years [23456789]. In Ibadan, the annual incidence for acute lymphoblastic leukemia and acute myeloblastic leukemia had been reported to be 3.7 per 106 per year and 1.9 per 106 per year respectively [23]. Acute leukaemias were also reported to be the commonest form of leukaemias in Ethiopia, constituting 63.8% of all cases reviewed, acute myeloid leukaemia(AML) being three times more common than acute lymphoblastic leukaemia(ALL) [6].In the United States of America, it was reported that haemopoietic malignancies accounted for approximately 6-8% of cancer incidence in both sexes, the incidence of acute leukemias being about 34 per million populations [78]. Malignant lymphomas have been among the most extensively studied neoplasms due to their rising incidence, the important insights they provide regarding cancer pathogenesis, the high treatment response rates and their potential curability [1011]. The annual incidence for non-Hodgkin’s lymphomas (NHL) was reported to be about eight cases per million populations among Zimbabweans [10]. In the United States of America (USA), the annual death rate from lympho-reticular malignancies is approximately 60 per million, of which Hodgkin’s lymphoma accounted for 35%, and NHL for more than 45% [11].The incidence rates for all lymphoid and granulocytic leukaemias in Ibadan for the period 1978-1982 ranged between 3.7 per 106 and 7.6 per 106 per year and between 5.0 per 106 to 10.0 per 106 per year re
机译:根据尼日利亚伊洛林大学教学医院病态记录部门的记录部门和癌症登记处的数据,对尼日利亚伊洛林的血液恶性肿瘤进行了为期10年的回顾性调查,目的是确定当前的血液病学模式研究范围内的恶性肿瘤,并与尼日利亚其他地区和世界范围内的先前报告进行比较。在研究期内(1996年1月至2005年12月)通过可用的血液学实验室方法和组织学检查诊断为370例血液学恶性肿瘤被分析。记录的各种血液系统恶性肿瘤的分布为:ALL 18(4.9%),AML 18(4.9%),CLL 20(5.4%),CML 42(11.4%),毛细胞白血病2(0.5%),NHL 104( 28.1%),霍奇金病42(11.4%),伯基特氏淋巴瘤102(27.5%),多发性骨髓瘤20(5.4%)和浆细胞白血病2(0.5%)淋巴瘤的患病率最高(67.0%),非霍奇金淋巴瘤最常见,约占淋巴瘤病例的42%。毛细胞白血病和浆细胞白血病的发生率最低,分别占病例的0.5%。该研究中各种血液系统恶性肿瘤的分布与以前的研究报道的模式相似,尽管总体上看患病率较低与早期发现相比,记录的血液系统恶性肿瘤发生率高。各种血液系统恶性肿瘤的管理困难和预后不良归因于晚期就诊,高患者违约率,贫穷和缺乏化疗药物。简介血液系统恶性肿瘤是血液和血液形成器官(即骨髓和淋巴组织)的原发性癌症。它们通常起源于克隆,并经常与染色体异常有关[1]。这些恶性肿瘤是由体细胞的遗传损伤或突变引起的,这可能是由环境因素(例如化学物质,电离辐射和病毒因素)引起的。这些恶性肿瘤的临床表现形式是可变的,并且在很大程度上取决于疾病的性质及其程度。它们分布于世界各地,可以在所有年龄段和男女中均出现。尽管就年龄和性别而言,各种类型之间存在差异,但多年来,各种社区均报告了临床表现和分布的变化模式[23456789]。据报道,在伊巴丹,急性淋巴细胞白血病和急性粒细胞白血病的年发病率分别为每年每106例3.7和每年每106例1.9 [23]。据报道,急性白血病也是埃塞俄比亚最常见的白血病形式,占所有病例的63.8%,急性髓细胞性白血病(AML)的发病率是急性淋巴细胞性白血病(ALL)的三倍[6]。在美国,据报道,造血系统恶性肿瘤约占男女癌症发生率的6-8%,急性白血病的发生率约为百万分之34 [78]。恶性淋巴瘤因其发病率上升,它们对癌症发病机理的重要见解,高治疗应答率及其潜在治愈性而成为研究最广泛的肿瘤之一[1011]。据报道,津巴布韦非霍奇金淋巴瘤(NHL)的年发病率约为百万分之八[10]。在美利坚合众国,每年因淋巴网状恶性肿瘤导致的死亡率约为60 /百万,其中霍奇金淋巴瘤占35%,NHL占45%以上[11]。 1978年至1982年期间,伊巴丹的淋巴样和粒细胞性白血病的发病率介于每年每106例3.7至106例之间,每年每106例5.0至10.0例之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号